Dr. Cassandra N. Moore, MD

Dr. Moore practices at Mayo Clinic Ambulatory Surgery Center - Scottsdale in Scottsdale, Arizona.

Dr. Moore's NPI, 1114966298, was assigned on June 5, 2006. Dr. Moore graduated from University of New Mexico School of Medicine in 1999. Dr. Moore holds North Carolina license 200201610.

Dr. Moore's primary practice is Mayo Clinic Ambulatory Surgery Center - Scottsdale, at 13400 East Shea Boulevard, Scottsdale, AZ 85259. The practice phone is (480) 342-4201.

Dr. Moore's primary practice is Mayo Clinic Ambulatory Surgery Center - Scottsdale in Scottsdale, Arizona. Dr. Moore is also affiliated with Mayo Clinic Hospital - Phoenix. The medical group on file is Mayo Clinic Arizona. Dmand AI also links Dr. Moore to 4 more hospitals and 1 medical group, each named with a free account. Dr. Moore's employer is on file too: a surgery center (asc).

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Moore practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Moore's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Moore's licenses on file in 2 states: North Carolina and Arizona.

Dmand AI lists breast cancer, chronic leukemia, colorectal cancer, fluid and electrolyte imbalances, lung cancer, lymphoma, multiple myeloma and prostate cancer among the conditions Dr. Moore treats.

CMS data shows 82,777 Medicare services from Dr. Moore across 56 procedure codes in 2024, for 1,175 Medicare patients. Medicare paid $1,672,302 for them. Every service was in an office.

CMS counts 1,175 Medicare patients who saw Dr. Moore in 2024. The largest group is 65 to 74, with 539 patients. 74% of them have high cholesterol, and 71% have high blood pressure. 3% are also on Medicaid. Their average risk score is 2.24, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Moore's median patient age at 74, with 28% women.

In 2024, Dr. Moore wrote 1,852 Medicare Part D claims for 239 patients. 79% of them were for generic drugs. CMS names the drug for 1,663 of them, across 21 drugs with 11 or more claims each, at $4,260,169 in total drug cost. In 2023, CMS named 885 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Moore for performance year 2024, reported as part of a group. Dr. Moore accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Moore as offering telehealth.

Dmand AI links 7 papers to Dr. Moore, published from 2012 to 2023. The most frequent topics are Docetaxel and Prostatic Neoplasms. Dr. Moore's most frequent co-authors are Alan Haruo Bryce, MD, Thai Huu Ho, MD, PhD and Parminder Singh, MD.

Dmand AI links Dr. Moore to 3 clinical trials. 1 is still active or recruiting. Conditions studied include Hematologic Neoplasms, Krukenberg Tumor and Carcinoma, Signet Ring Cell.

CMS Open Payments shows 13 general payments to Dr. Moore from 8 drug and device companies from 2017 to 2025. Speaker and faculty fees make up the largest share, 80% of the total. Janssen Pharmaceuticals, Inc paid the most, $3,488.

Dr. Moore graduated from University of New Mexico School of Medicine in 1999.

Dr. Moore is in network with 9 carriers, including Elevance, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 5. Check the plan with the practice before a visit.